Ads
related to: astrazeneca fasenra- FASENRA Cost & Savings
Learn About The FASENRA Savings
Program & See If You're Eligible.
- Administration Options
With FASENRA You May Have Options.
View At-Home & Self-Admin Info.
- Considering FASENRA?
It May Be Time To Think Differently
About Your Treatment Options.
- FASENRA 360
Sign Up For Personalized Resources
For Your FASENRA Journey.
- Patient Resources
Find Support Resources You May Need
When Starting FASENRA.
- Access FAQ
See Answers To Your Questions About
Your Condition & The FASENRA Pen.
- FASENRA Cost & Savings
Search results
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
Zacks via Yahoo Finance· 16 hours agoAstraZeneca AZN announced its long-term plan to generate $80 billion in total revenues by 2030,...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 20 hours agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids
Zacks via Yahoo Finance· 1 month agoAstraZeneca AZN announced that the FDA has approved its marketed asthma drug, Fasenra...
AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus Inflammation
Benzinga via Yahoo Finance· 2 years agoAstraZeneca Plc (NASDAQ: AZN) has reported topline data from the MESSINA Phase 3 trial Fasenra...
AstraZeneca (AZN) Key Drugs to Aid Growth, Pipeline Strong
Zacks via Yahoo Finance· 8 months agoAstraZeneca's (AZN) key drugs like Lynparza, Tagrisso, Fasenra and Farxiga should keep driving...
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Pharmaceutical Technology via Yahoo Finance· 3 weeks agoAstraZeneca has recently announced that Fasenra has been approved for severe asthma, specifically...
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 4 weeks agoAstraZeneca’s AZN first-quarter 2024 core earnings of $1.03 per American depositary share (ADS) beat...
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
Zacks via Yahoo Finance· 6 months agoAstraZeneca’s AZN third-quarter 2023 core earnings of 87 cents per American depositary share (ADS)...
AstraZeneca (AZN) Q1 Earnings Beat, COVID Products Hurt Sales
Zacks via Yahoo Finance· 1 year agoAstraZeneca’s AZN first-quarter 2023 core earnings of 96 cents per American depositary share (ADS)...
AstraZeneca (AZN) Q2 Earnings & Sales Beat, Nil COVID Sales
Zacks via Yahoo Finance· 10 months agoAstraZeneca (AZN) beats second-quarter estimates for earnings and sales. The company did not...
Ads
related to: astrazeneca fasenra
